{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:01:01Z","timestamp":1748822461212},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Hospitals Authority\u2019 Ascent Plan","award":["DFL20190201"],"award-info":[{"award-number":["DFL20190201"]}]},{"name":"Natural Science Foundation of Beijing","award":["7222025"],"award-info":[{"award-number":["7222025"]}]},{"name":"Beijing Science and Technology Rising Star Program-Cross-cooperation","award":["20220484218"],"award-info":[{"award-number":["20220484218"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To examine the clinical characteristics, diagnosis and treatment, and prognosis of ocular amyloidosis in a Chinese population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective case series study was conducted. The clinical data of 37 patients with ocular amyloidosis were collected and the clinical characteristics, diagnosis and treatment, and prognosis were summarized and analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The 37 patients included 12 males and 25 females ranging in age from 22 to 75 years, with median age of 49 years. The clinical signs and symptoms included a conjunctival mass in 37 patients (100%), periorbital discomfort or pain in 29 patients (61.9%), ptosis in 18 patients (23.8%), exophthalmos or eyeball displacement in 3 patients (14.3%), restricted eye movement in 2 patients (9.52%), vision loss in 1 patient (4.76%), and diplopia in 1 patient (4.76%). A total of 29 patients had only conjunctival involvement and 8 patients had concomitant orbital and conjunctival involvement. The main treatment for patients with conjunctival involvement was surgical resection. Thirty-one patients had stable disease, 4 patients progressed or relapsed, and 2 patients were lost to follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Ocular amyloidosis most commonly presents as an eyelid or conjunctival mass or diffuse thickening and can also present as an orbital mass. Diagnosis is mainly dependent on histopathological examination. Surgery is the main treatment and is done to confirm the diagnosis to guide further treatment, preserve function, and prevent complications that threaten visual acuity. Close postoperative follow-up is necessary.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03548-w","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T07:01:48Z","timestamp":1721286108000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical analysis of 37 Chinese patients with ocular amyloidosis: a single center study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"4","key":"3548_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000506617","volume":"143","author":"I Vaxman","year":"2020","unstructured":"Vaxman I, Gertz M. When to suspect a diagnosis of amyloidosis. Acta Haematol. 2020;143(4):304\u201311.","journal-title":"Acta Haematol"},{"issue":"1","key":"3548_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jama.2020.5493","volume":"324","author":"MA Gertz","year":"2020","unstructured":"Gertz MA, Dispenzieri A. Systemic amyloidosis Recognition, Prognosis, and therapy: a systematic review. JAMA. 2020;324(1):79\u201389.","journal-title":"JAMA"},{"issue":"10038","key":"3548_CR3","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"M Singh","year":"2016","unstructured":"Singh M, Rao KR, Das A, Wechalekar AD, Gillmore JD, Hawkins PN. Lancet. 2016;387(10038):2641\u201354.","journal-title":"Lancet"},{"issue":"4","key":"3548_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000508022","volume":"143","author":"B Wisniowski","year":"2020","unstructured":"Wisniowski B, Wechalekar A. Confirming the diagnosis of amyloidosis. Acta Haematol. 2020;143(4):312\u201321.","journal-title":"Acta Haematol"},{"issue":"9","key":"3548_CR5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.ophtha.2006.03.052","volume":"113","author":"I Leibovitch","year":"2006","unstructured":"Leibovitch I, Selva D, Goldberg RA, Sullivan TJ, Saeed P, Davis G, et al. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology. 2006;113(9):1657\u201364.","journal-title":"Ophthalmology"},{"issue":"2","key":"3548_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10792-015-0138-7","volume":"36","author":"ER Mora-Horna","year":"2016","unstructured":"Mora-Horna ER, Rojas-Padilla R, L\u00f3pez VG, Guzm\u00e1n MJ, Ceriotto A, Salcedo G. Ocular adnexal and orbital amyloidosis: a case series and literature review. Int Ophthalmol. 2016;36(2):281\u201398.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"3548_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/09273948.2013.850100","volume":"22","author":"J Batra","year":"2014","unstructured":"Batra J, Ali MJ, Mody K, Naik MN, Vemuganti GK. Lacrimal gland amyloidosis: a clinicopathological correlation of a rare disorder and review of literature. Ocul Immunol Inflamm. 2014;22(4):300\u20135.","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"3548_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/IOP.0000000000002061","volume":"38","author":"JY Tong","year":"2022","unstructured":"Tong JY, Juniat V, McKelvie PA, O\u2019Donnell BA, Hardy TG, McNab AA, Selva D. Clinical and radiological features of intramuscular orbital amyloidosis: a case series and literature review. Ophthalmic Plast Reconstr Surg. 2022;38(3):234\u201341.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"3548_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/01676830.2019.1594988","volume":"39","author":"S Kang","year":"2020","unstructured":"Kang S, Dehabadi MH, Rose GE, Verity DH, Amin S, Das-Bhaumik R. Ocular amyloid: adnexal and systemic involvement. Orbit. 2020;39(1):13\u20137.","journal-title":"Orbit"},{"issue":"7","key":"3548_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/genes12070955","volume":"12","author":"AM Minnella","year":"2021","unstructured":"Minnella AM, Rissotto R, Antoniazzi E, Di Girolamo M, Luigetti M, Maceroni M, Bacherini D, Falsini B, Rizzo S, Obici L. Ocular involvement in Hereditary Amyloidosis. Genes (Basel). 2021;12(7):955.","journal-title":"Genes (Basel)"},{"issue":"4","key":"3548_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/IAE.0000000000003378","volume":"42","author":"A Marta","year":"2022","unstructured":"Marta A, Marques JH, Ferreira A, Coelho J, Beir\u00e3o JM. Choroidal involvement in hereditary transthyretin amyloidosis patients. Retina. 2022;42(4):775\u201381.","journal-title":"Retina"},{"issue":"5","key":"3548_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.4103\/ijo.IJO_2528_20","volume":"69","author":"P Banerjee","year":"2021","unstructured":"Banerjee P, Alam MS, Subramanian N, Kundu D, Koka K, Poonam NS, Mukherjee B. Orbital and adnexal amyloidosis: thirty years experience at a tertiary eye care center. Indian J Ophthalmol. 2021;69(5):1161\u20136.","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"3548_CR13","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1148\/rg.2020200068","volume":"40","author":"M Hotta","year":"2020","unstructured":"Hotta M, Minamimoto R, Awaya T, Hiroe M, Okazaki O, Hiroi Y. Radionuclide imaging of cardiac amyloidosis and sarcoidosis: roles and characteristics of various tracers. Radiographics. 2020;40(7):2029\u201341.","journal-title":"Radiographics"},{"issue":"5","key":"3548_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3349\/ymj.2021.62.5.431","volume":"62","author":"EN Cheong","year":"2021","unstructured":"Cheong EN, Paik W, Choi YC, Lim YM, Kim H, Shim WH, Park HJ. Clinical features and brain MRI findings in Korean patients with AGel Amyloidosis. Yonsei Med J. 2021;62(5):431\u20138.","journal-title":"Yonsei Med J"},{"issue":"4","key":"3548_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5812\/iranjradiol.4555","volume":"8","author":"H Yerli","year":"2011","unstructured":"Yerli H, Aydin E, Avci S, Haberal N, Oto S. Focal amyloidosis of the orbit presenting as a Mass: MRI and CT features. Iran J Radiol. 2011;8(4):241\u20134.","journal-title":"Iran J Radiol"},{"issue":"1","key":"3548_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/08820538.2019.1687738","volume":"35","author":"R Dammacco","year":"2020","unstructured":"Dammacco R, Merlini G, Lisch W, Kivel\u00e4 TT, Giancipoli E, Vacca A, Dammacco F. Amyloidosis and ocular involvement: an overview. Semin Ophthalmol. 2020;35(1):7\u201326.","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"3548_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000506696","volume":"143","author":"MM Picken","year":"2020","unstructured":"Picken MM. The Pathology of Amyloidosis in classification: a review. Acta Haematol. 2020;143(4):322\u201334.","journal-title":"Acta Haematol"},{"issue":"7","key":"3548_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1080\/10428194.2021.1873320","volume":"62","author":"I Vaxman","year":"2021","unstructured":"Vaxman I, Gertz MA. Measurable residual disease in multiple myeloma and light chain amyloidosis: more than meets the eye. Leuk Lymphoma. 2021;62(7):1544\u201353.","journal-title":"Leuk Lymphoma"},{"key":"3548_CR19","doi-asserted-by":"crossref","unstructured":"Hanumanthu V, Thakur V, Chatterjee D, Vinay K. QJM. Periocular cutaneous amyloidosis in multiple myeloma. 2021;114(8):603\u20134.","DOI":"10.1093\/qjmed\/hcab084"},{"issue":"2","key":"3548_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cll.2021.03.003","volume":"41","author":"DL Murray","year":"2021","unstructured":"Murray DL, Dasari S. Clinical Mass Spectrometry approaches to Myeloma and Amyloidosis. Clin Lab Med. 2021;41(2):203\u201319.","journal-title":"Clin Lab Med"},{"issue":"9","key":"3548_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.ophtha.2006.03.052","volume":"113","author":"I Leibovitch","year":"2006","unstructured":"Leibovitch I, Selva D, Goldberg RA, Sullivan TJ, Saeed P, Davis G, McCann JD, McNab A, Rootman J. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology. 2006;113(9):1657\u201364.","journal-title":"Ophthalmology"},{"issue":"3","key":"3548_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/01676830.2020.1852578","volume":"41","author":"CS Chean","year":"2022","unstructured":"Chean CS, Sovani V, Boden A, Knapp C. Lacrimal gland extranodal marginal zone B-cell lymphoma in the presence of amyloidosis. Orbit. 2022;41(3):350\u20133.","journal-title":"Orbit"},{"issue":"19","key":"3548_CR23","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/blood.2020008737","volume":"139","author":"G Palladini","year":"2022","unstructured":"Palladini G, Merlini G. How I treat AL amyloidosis. Blood. 2022;139(19):2918\u201330.","journal-title":"Blood"},{"issue":"9","key":"3548_CR24","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","volume":"34","author":"R Ry\u0161av\u00e1","year":"2019","unstructured":"Ry\u0161av\u00e1 R. AL amyloidosis: advances in diagnostics and treatment. Nephrol Dial Transpl. 2019;34(9):1460\u20136.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"3548_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01.iop.0000222509.32005.78","volume":"22","author":"C Tyradellis","year":"2006","unstructured":"Tyradellis C, Peponis V, Kulwin DR. Surgical management of recurrent localized eyelid amyloidosis. Ophthalmic Plast Reconstr Surg. 2006;22(4):308\u20139.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"3548_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/01676830.2018.1483407","volume":"38","author":"TS Copperman","year":"2019","unstructured":"Copperman TS, Truong MT, Berk JL, Sobel RK. External beam radiation for localized periocular amyloidosis: a case series. Orbit. 2019;38(3):210\u20136.","journal-title":"Orbit"},{"issue":"6","key":"3548_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/01676830802350216","volume":"27","author":"M Khaira","year":"2008","unstructured":"Khaira M, Mutamba A, Meligonis G, Rose GE, Plowman PN, O\u2019Donnell H. The use of radiotherapy for the treatment of localized orbital amyloidosis. Orbit. 2008;27(6):432\u20137.","journal-title":"Orbit"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03548-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03548-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03548-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T07:03:34Z","timestamp":1721286214000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03548-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3548"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03548-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained for the experiments. All methods were carried out in accordance with relevant guidelines and regulations. This study was conducted in accordance with the principles of the Helsinki Declaration and was approved by the Ethics Committee of Beijing Tongren Hospital, Capital Medical University (TRECKY2019-093).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}